C50-C50
Conditions
Interventions
Group 1: Women who enter this study will be diagnosed either as breast cancer cases or controls without breast cancer. The definitions are as follows: Cases are patients, who have a histologically con
Sponsors
Frauenklinik des Uniklinikums Erlangen
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: 1) Signed informed consent. 2) Indication for a routine mammogram and ultrasound (indication for this examination is not allowed to be made within the study. The examination must be part of routine examinations for diagnostic purposes).
Exclusion criteria
Exclusion criteria: 1) Previous diagnosis of breast cancer or precursor lesions such as DCIS or atypical ductal or lobular hyperplasia 2) Indication for a mammogram or an ultrasound which is not a routine examination 3) Indication for a mammogram as part of a follow up examination for a previous BIRADS 3 assessment of any imaging method 4) Unknown reason for the presentation or the referral of the patient.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| We intend to investigate the diagnostic accuracy of several imaging techniques, which are used in clinical routine (mobile ultrasound, routine mammography and routine ultrasound with conventional ultrasound machines). The primary study aim is the improvement of the diagnostic accuracy of routine mammography and the identification of risk factors for breast cancer at the timepoint of primary diagnosis. | — |
Secondary
| Measure | Time frame |
|---|---|
| Several secondary study aims (SSA) will be pursued within this study and are concerned mainly with the correlation of imaging, tumor and patient characteristics with the diagnostic accuracy either for breast cancer in general, for specific subtypes of breast cancer or metastasis. | — |
Countries
Germany
Contacts
Public ContactPeter A. Fasching
Frauenklinik des Uniklinikums Erlangen
Outcome results
None listed